Financial Performance - For the six months ended September 30, 2023, the total revenue was HK$240,086,000, a decrease from HK$243,482,000 as of March 31, 2023[8]. - The company reported a loss for the period of HK$13,050,000, compared to a profit of HK$3,411,000 in the previous period[10]. - The Group's revenue for the six months ended September 30, 2023, was approximately HK$237.0 million, an increase of approximately HK$25.1 million or 11.8% compared to HK$211.9 million for the same period in 2022[35]. - Loss attributable to the owners of the Company was approximately HK$13.1 million for the six months ended September 30, 2023, compared to a profit of approximately HK$3.4 million for the same period in 2022[35]. - Total comprehensive loss for the period was HK$13.2 million, compared to a comprehensive income of HK$3.3 million for the same period in 2022[36]. - The Group reported a loss before tax of HK$13,050,000 for the six months ended September 30, 2023, compared to a profit of HK$3,411,000 in the same period of 2022[122]. - The Group recorded a loss of HK$13.1 million for the period, compared to a profit of HK$3.4 million in the previous period[159]. Revenue Breakdown - Revenue from contracts with customers for the six months ended September 30, 2023, was HK$237,010,000, an increase of 11.8% from HK$211,900,000 in the same period of 2022[112]. - Revenue from Hong Kong was HK$215,069,000, up 5.9% from HK$203,124,000 year-on-year[73]. - Revenue from Mainland China surged to HK$21,941,000, a significant increase of 149.5% compared to HK$8,776,000 in the previous year[73]. - Treatment services revenue increased to HK$176,335,000, up from HK$153,569,000, representing a growth of 14.8% year-over-year[113]. - Skincare products revenue rose to HK$60,631,000, compared to HK$58,120,000, marking a 4.3% increase[113]. Assets and Liabilities - Total current assets as of September 30, 2023, were HK$272,953,000, slightly down from HK$273,329,000 as of March 31, 2023[8]. - The total non-current assets decreased to HK$240,086,000 from HK$243,482,000[8]. - The company’s total equity as of September 30, 2023, was HK$137,525,000, a decrease from HK$150,713,000 as of April 1, 2023[10]. - Net current liabilities increased to HK$24.8 million as of September 30, 2023, compared to HK$13.2 million as of March 31, 2023[38]. - Total assets less current liabilities amounted to HK$215.3 million as of September 30, 2023, down from HK$230.2 million as of March 31, 2023[38]. - Non-current liabilities totaled HK$77.8 million as of September 30, 2023, slightly decreased from HK$79.5 million as of March 31, 2023[38]. - Net assets decreased to HK$137.5 million as of September 30, 2023, from HK$150.7 million as of March 31, 2023[38]. Cash Flow and Investments - Net cash flows from operating activities for the six months ended September 30, 2023, were HK$24,581,000, a decrease from HK$54,118,000 in the same period last year[11]. - Net cash flows used in investing activities amounted to HK$25,820,000, compared to HK$19,426,000 in the previous year, indicating increased investment outflows[11]. - Cash and cash equivalents were reported at HK$97,784,000, down from HK$116,911,000[8]. - Cash and cash equivalents at the end of the period were HK$77,329,000, down from HK$80,802,000 at the end of the previous period[11]. - The total cash and cash equivalents at the beginning of the period were HK$105,610,000, showing a decrease in liquidity during the reporting period[11]. Operational Focus and Strategy - The company plans to focus on market expansion and new product development in the upcoming quarters[5]. - The Group expanded its CosMax+ operation scale by approximately 4,000 square feet to enhance customer experience[157]. - The Group's marketing expenses increased due to the expansion into the Mainland market, impacting overall profitability[161]. - The Group's two brands, CosMax+ and VITAE, are positioned to leverage synergies and enhance market coverage[162]. - The Group plans to adopt a cautiously optimistic approach in the second half of the year, focusing on improving management and operational efficiency[190]. Compliance and Governance - The interim financial information has been prepared in accordance with Hong Kong Accounting Standards, ensuring compliance with local regulations[12]. - The Group has adopted new and revised Hong Kong Financial Reporting Standards (HKFRSs) effective from April 1, 2023, which did not impact the interim financial information but will affect annual disclosures[80]. - The Group's accounting policies remain consistent with those applied in the previous fiscal year, with no significant impact from recent amendments[87]. - The Group did not experience any material impact on liquidity from exchange rate fluctuations and did not engage in hedging transactions during the review period[200]. Shareholder Information - The Board did not declare an interim dividend for the six months ended September 30, 2023, consistent with the previous year[35]. - The average number of ordinary shares issued during the period was 400,000,000, consistent with the previous period[144].
卓珈控股(01827) - 2024 - 中期财报